Skip to main content
Afaf E. Osman
( out of 31 reviews )

Afaf E. Osman, MD

Languages spoken: Arabic, English
  • Afaf Osman recently graduated from the University of Chicago Hematology/Oncology Fellowship program where she was a leukemia fellow for two years. Her clinical interest is in myeloid malignancies. Her research interest is in studying clonal hematopoiesis as a precursor condition to myeloid malignancies. Prior to fellowship, she was an internal medicine resident at the Johns Hopkins hospital in Baltimore.

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Patient Rating

    4.9 /5
    ( out of 31 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 24, 2023
    HUNTSMAN CANCER CENTER

    Dr Osman always answered my questions and she never made me feel like I was using too much of her time. She is one of those special doctors that you can feel confident in, knowing that she has your best interests at heart. Thank you for being on this journey with me.

    September 19, 2023
    HUNTSMAN CANCER CENTER

    Dr. Osman is kind, empathetic, but most importantly very knowledgeable.

    August 21, 2023
    HUNTSMAN CANCER CENTER

    She is amazing and kind, professional and so very, very smart.

    June 17, 2023
    HUNTSMAN CANCER CENTER

    Awesome! Dr. Osman is the perfect fit for me and managing my health care problems. She cares about how I feel and provides great education, then includes me in my treatment plan.

    May 14, 2023
    HUNTSMAN CANCER CENTER

    She is a very compassionate person and very knowledgeable in her profession. We are happy with her as our Hematologist and in caring for Ken's disease Vexas.

    April 09, 2023
    HUNTSMAN CANCER CENTER

    I feel like I'm in good hands with Dr. Osman I trust that she is working toward my best interests.

    April 05, 2023
    HUNTSMAN CANCER CENTER

    Dr. Osman is caring and concerned about my health. I feel comfortable discussing my disease and treatment options; plus she consults with other physicians to assure I am getting the best care for me. Nothing but gratitude for her care!!

    April 03, 2023
    HUNTSMAN CANCER CENTER

    She was great. Only doctor Ive seen who looked at the whole picture.

    March 13, 2023
    HUNTSMAN CANCER CENTER

    Dr. Osman follows my disease closely and works for the best outcome. Wonderful care! Also, has a caring team!

  • Afaf Osman recently graduated from the University of Chicago Hematology/Oncology Fellowship program where she was a leukemia fellow for two years. Her clinical interest is in myeloid malignancies. Her research interest is in studying clonal hematopoiesis as a precursor condition to myeloid malignancies. Prior to fellowship, she was an internal medicine resident at the Johns Hopkins hospital in Baltimore.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Hematology
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Education history

    Fellowship Leukemia - University of Chicago Research Fellow
    Hematology & Oncology - University of Chicago Clinical Fellow
    Residency Internal Medicine - Johns Hopkins Hospital Resident
    Medicine - Weill Cornell Medical College in Qatar M.D.
    Certification Premedical Program - Weill Cornell Medical College in Qatar Pre Med

    Selected Publications

    Journal Article

    1. Osman A, Mencia-Trinchant N, Saygin C, Moma L, Kim A, Housman G, Pozsgai MJ, Sinha E, Chandra P, Hassane DC, Sboner A, Sangani K, DiNardi N, Johnson C, Wallace SS, Jabri B, Luu H, Guzman ML, Desai P, Godley LA (2022). Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones. Blood Adv. (Read full article)
    2. Yu B, Osman AEG, Sladojevic N, Prabhu N, Tai HC, Chen D, Perla G, Park L, Larson RA, Liao JK (2022). Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular Toxicity. JACC CardioOncol, 4(3), 371-383. (Read full article)
    3. Feusier JE, Madsen MJ, Avery BJ, Williams JA, Stephens DM, Hu B, Osman AEG, Glenn MJ, Camp NJ (2021). Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates CXCR4 in inherited risk. J Transl Genet Genom, 5, 189-199. (Read full article)
    4. Feurstein S, Adegunsoye A, Mojsilovic D, Vij R, DePersia AHW, Rajagopal PS, Osman A, Collins RH, Kim RH, Gore SD, Greenberg P, Godley LA, Li Z, Del Gaudio D, Subramanian HP, Das S, Walsh T, Gulsuner S, Segal JP, Husain AN, Gurbuxani S, King MC, Strek ME and Churpek JE (2020). Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations. Blood Adv, 4(19), 4873-4886.
    5. Osman A, Gocke CD, Gladstone DE (2016). Change in IgHV Mutational Status of CLL Suggests Origin From Multiple Clones. Clin Lymphoma Myeloma Leuk, 17(2), 97-99. (Read full article)
    6. Osman A, et al (2014). Sudden Worsening of DRESS Syndrome on Tapering Steroid Dose with Dramatic Improvement on N-acetylcysteine and Steroid Dose Escalation. 6(2), 101-10.

    Review

    1. Liu J, Osman AEG, Bolton K, Godley LA (2023). Germline predisposition to clonal hematopoiesis. [Review]. Leuk Res, 132, 107344. (Read full article)
    2. Croci DM, Gamboa NT, Osman AEG, Maese L, Mazur M, Bisson EF, Dailey AT (2021). Solitary manifestations of primary B-lymphoblastic lymphoma of the spine: Systematic literature review with case illustration. [Review]. Clin Neurol Neurosurg, 212, 107064. (Read full article)
    3. Osman AEWG (2021). When are idiopathic and clonal cytopenias of unknown significance (ICUS or CCUS)? [Review]. Hematology Am Soc Hematol Educ Program, 2021(1), 399-404. (Read full article)
    4. Osman AEG, Deininger MW (2021). Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions. [Review]. Blood Rev, 49, 100825. (Read full article)
    5. Osman A, Patel JL (2021). Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis. [Review]. Clin Chem, 67(8), 1062-1070. (Read full article)
    6. Osman AEG, Luke JJ (2019). The Impact of the Fecal Microbiome on Cancer Immunotherapy. [Review]. BioDrugs, 33(1), 1-7. (Read full article)
    7. Akpan IJ, Osman AEG, Drazer MW, Godley LA (2018). Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies. [Review]. Curr Hematol Malig Rep, 13(6), 426-434. (Read full article)
    8. Osman AEG, Anderson J, Churpek JE, Christ TN, Curran E, Godley LA, Liu H, Thirman MJ, Odenike T, Stock W, Larson RA (2018). Treatment of Acute Promyelocytic Leukemia in Adults. [Review]. J Oncol Pract, 14(11), 649-657. (Read full article)

    Case Report

    1. Osman A, Galiatsatos P, Bose S, Danoff S (2017). Rheumatoid arthritis causing diffuse alveolar haemorrhage: a novel therapeutic approach. BMJ Case Rep, 2017. (Read full article)

    Abstract

    1. Osman AYu B, Glavin N, Polonsky T, Liao J, Larson RA (2018). ABL Tyrosine Kinase Inhibitors (TKIs) are Associated with Increased Rho-Associated Kinase (ROCK) Activity that May Contribute to Vascular Toxicity in Patients with Chronic Myeloid Leukemia (CML). Poster session: 632 Chronic Myeloid Leukemia: Therapy, American Society of Hematology 60th Annual Meeting, San Diego, CA [Abstract]. 132(Suppl 1), 1739.
    2. Osman AGaliatsatos PBose S (2017). Diffuse Alveolar Hemorrhage as a Rare Manifestation of Rheumatoid Arthritis. Poster session presented at the Autoimmune Lung Disease: Case Reports Thematic Poster Session. American Thoracic Society International Conference, Washington, DC [Abstract]. 195, A1460.

    Other

    1. Osman AEG, Luke JJ (2019). The Gut Microbiome and Cancer Immunotherapy. (4(8), pp. 14-5).
  • News & Podcasts